Twist Bioscience stock drops 3.5% as brand delivers swag event at Caltech, Twist Bioscience

Traders Union
All News
Business & Wealth
Companies
Twist Bioscience drops 3.48% today

Highlights

TWST remains in a medium- and long-term bullish trend despite recent short-term selling pressure and a 5.3% weekly decline.
Technical indicators show mixed momentum and oversold conditions, with bearish positioning dominating the near term as sellers maintain control.
Price is expected to move sideways next week within an $82.00 to $94.00 range, with $81.84 as key support and $93.48 resistance.

Twist Bioscience expressed appreciation for the warm welcome received at Caltech. The company stated there is nothing better than seeing how Twist DNA enables research.

View post on X Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Short-term downside risk as price holds above key moving averages

TWST is trading at $85.47, below the MA-20 ($92.37), above the MA-50 ($81.84), and well above the MA-200 ($51.97), indicating short-term downward pressure but continued support for a medium- and long-term bullish trend. The Ichimoku Kijun level at $93.48 stands as immediate resistance. Near-term support is at the MA-50 ($81.84), with key support at the MA-100 ($67.02). Immediate resistance lies at the MA-20 ($92.37), with the Ichimoku Kijun ($93.48) serving as key resistance.

Divergent momentum and oversold signals as weekly decline accelerates

Momentum indicators show a mixed outlook on D1. MACD signals strong buy while ADX points to a sell, highlighting a divergence between trend and momentum. RSI (45.78), Stoch RSI (0.00), and CCI (–149.58) all point to oversold conditions, and BBP (–0.81) confirms sellers currently dominate, while AO reinforces the downside bias. TWST has fallen $4.80 (5.32%) over the past week, dropping from $90.27 to its current level and now sits at the very bottom of the weekly range. Weekly volatility stands at 17.66%. This confirms a clear, steady decline from the recent highs. In today's session, the stock has seen a notable daily drop of 3.48% as sellers maintain control.

Bullish rebound probability rises as market consolidates after sell-off

Looking ahead, the expected price range for the coming week is $82.00 to $94.00, which captures typical weekly swings and keeps the range within 15% of the current level. This forecast sits well above the 52-week low ($23.30) but remains under the 52-week high ($105.41). Based on W1 data—where RSI, ADX, MACD, and all major MAs continue to signal “Buy”—the probability of a price increase is very high (more than 80%), making further declines less likely. The baseline scenario anticipates sideways action between support and resistance as the market stabilizes following the recent sell-off. The bullish scenario would see TWST break above $93.48, targeting recovery towards the weekly average, while a bearish scenario could see a further test of support at $81.84 and possibly $67.00 if downside momentum grows.

Earlier, analysts noted that Twist Bioscience was maintaining a bullish long-term outlook despite short-term technical pressures and market volatility. In light of recent market developments, investors should closely monitor for a shift in momentum signals that could confirm a sustained recovery or indicate renewed downside risk.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.